drugset / Trial / NCT01279252

CLL Empirical Antibiotic Regimen

NCT01279252

Phase 2 Completed 71 enrolled King's College Hospital NHS Trust
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate whether patients with previously untreated, early stage CLL respond to empirical broad spectrum antibiotics and therefore test the hypothesis that occult bacterial infections are involved in the induction and maintenance of CLL.

Timeline

Start
2011-07
Primary completion
2015-01
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciprofloxacin Small molecule
Subject Clarithromycin Small molecule
Subject Lansoprazole Other / unclassified
Subject Metronidazole Small molecule